# Sub-Q Bionics Licenses Clinical Know-How from Mayo Clinic to Advance Implantable Lymphedema System

> partnership · REPORTED · 2026-03-18

Sub-Q Bionics announced a licensing agreement with Mayo Clinic covering clinical knowledge related to reconstructive and lymphatic surgery, and added Mayo Clinic plastic and reconstructive surgeon Vahe Fahradyan, MD, as a clinical collaborator. This followed the company's March 2026 close of a $1.5 million pre-seed round backed by Mayo Clinic, Yeda, and the Israel Innovation Authority.

About Sub-Q Bionics, Inc.: Sub-Q Bionics is a medical device company developing the world's first implantable bionic lymphatic drainage system, designed to help patients living with lymphedema manage symptoms such as swelling and pain through automatic subcutaneous fluid management.

- Company: Sub-Q Bionics, Inc.
- Sector: medical devices
- Primary source: https://www.biospace.com/press-releases/sub-q-bionics-announces-licensing-agreement-to-advance-lymphedema-care

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.